News

Mauna Kea Technologies reports fourth quarter and full year 2019 sales

29 January 2020

 Full Year 2019 total sales up 10% 
Sales to clinical customers up 27%, driven by 89% growth in consumables sales related to pay-per-use program 

Fourth Quarter total sales down 20% 
Fourth quarter sales to clinical customers down 18%, driven by 29% increase in consumables sales which partially offset expected year-over-year decline in US capital sales 

Latest News

Mauna Kea Technologies Announces Expanded Clinical Evidence for Cellvizio® To Be Presented at Digestive Disease Week® 2026 

Mauna Kea Technologies Announces Expanded Clinical Evidence for Cellvizio® To Be Presented at Digestive Disease Week® 2026 

Mauna Kea Technologies Reports FY 2025 Financial Results: Comprehensive Debt Restructuring and Reaccelerating Organic Growth Mark a Transformative 2025 

Mauna Kea Technologies Reports FY 2025 Financial Results: Comprehensive Debt Restructuring and Reaccelerating Organic Growth Mark a Transformative 2025 

Mauna Kea Technologies Reports Strong Q1 2026 Core Sales Growth 

Mauna Kea Technologies Reports Strong Q1 2026 Core Sales Growth 

No results found.